Organization Overview
Alternative names
acetylsalicylic acid (aspirin) (2 trials)
adefovir dipivoxil (hepsera) (5 trials)
adenosine monophosphate (1 trial)
albumin (Human) (Plasbumin) (1 trial)
amlodipine (norvasc) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (6 trials)
atorvastatin (lipitor) (1 trial)
Atosiban (tractocile) (1 trial)
beclomethasone (vanceril) (2 trials)
budesonide (rhinocort) (5 trials)
butorphanol (stadol) (1 trial)
ceftazidime (fortaz) (1 trial)
cenegermin-bkbj (oxervate) (1 trial)
cisatracurium (nimbex) (2 trials)
clarithromycin (biaxin) (2 trials)
clopidogrel (plavix) (1 trial)
cyclophosphamide (cytoxan) (27 trials)
cyclosporine (sandimmune) (4 trials)
enoxaparin (lovenox) (1 trial)
entecavir (baraclude) (9 trials)
esketamine (spravato) (3 trials)
esomeprazole (nexium) (1 trial)
etanercept (enbrel) (3 trials)
etoposide (vepesid) (10 trials)
formoterol (foradil) (6 trials)
glyburide (micronase) (1 trial)
human choriogonadotropin alfa (hCG) (2 trials)
hydromorphone (diladid) (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
idarubicin (idamycin) (7 trials)
insulin aspart (Novolog) (1 trial)
insulin lispro (humalog) (1 trial)
interferon alpha-2b (Intron-A) (4 trials)
linagliptin (tradjenta) (1 trial)
mercaptopurine (purinethol) (3 trials)
metformin (glucophage) (1 trial)
methacholine (provocholine) (1 trial)
metoprolol (lopressor) (1 trial)
mycophenolate (CellCept) (5 trials)
octreotide (sandostatin) (1 trial)
oseltamivir (tamiflu) (1 trial)
prednisone (meticorten) (7 trials)
progesterone (progestasert) (1 trial)
propofol (diprivan) (7 trials)
rivaroxaban (xarelto) (1 trial)
rocuronium (zemuron) (1 trial)
rosuvastatin (crestor) (1 trial)
saxagliptin (onglyza) (1 trial)
sevoflurane (ultane) (2 trials)
sitagliptin (januvia) (1 trial)
sorafenib (nexavar) (5 trials)
spironolactone (aldactone) (1 trial)
sulfasalazine (azulfidine) (1 trial)
telbivudine (tyzeka) (3 trials)
telmisartan (micardis) (1 trial)
tenofovir alafenamide (genvoya) (1 trial)
terlipressin (Terlivaz) (2 trials)
thymalfasin (zadaxin) (2 trials)
ticagrelor (brilinta) (1 trial)
tofacitinib (xeljanz) (1 trial)
vecuronium (norcuron) (1 trial)
vincristine (oncovin) (8 trials)
131i-lipiodol (Lipiodol) (2 trials)
acetylcysteine (mucomyst) (1 trial)
alemtuzumab (campath) (1 trial)
allogeneic blood cells (3 trials)
allogeneic lymphocytes (2 trials)
alteplase (Activase) (1 trial)
autologous mesenchymal stem cells (13 trials)
azacitidine (vidaza) (6 trials)
azathioprine (imuran) (1 trial)
bevacizumab (avastin) (5 trials)
bleomycin (blenoxane) (1 trial)
bone marrow derived mesenchymal stem cells (2 trials)
busulfan (Myleran) (14 trials)
capecitabine (xeloda) (11 trials)
carboplatin (paraplatin) (6 trials)
cd25 monoclonal antibody (1 trial)
cord blood hematopoietic stem cell (1 trial)
cytarabine (cytosar-u) (10 trials)
daclatasvir (daklinza) (1 trial)
dasatinib (sprycel) (2 trials)
decitabine (dacogen) (13 trials)
docetaxel (taxotere) (2 trials)
doxorubicin (Doxil) (8 trials)
eltrombopag (promacta) (1 trial)
epirubicin (ellence) (3 trials)
Filgrastim (neupogen) (4 trials)
fludarabine (fludara) (7 trials)
fluorouracil (efudex) (6 trials)
indocyanine green (ic-green) (4 trials)
irinotecan (Camptosar) (3 trials)
ledipasvir (Harvoni) (2 trials)
megakaryocytic progenitor cells (1 trial)
melphalan (alkeran) (3 trials)
mitomycin (mutamycin) (1 trial)
mitoxantrone (novantrone) (1 trial)
monosialoganglioside (1 trial)
ombitasvir (Viekira Pak) (1 trial)
oprelvekin (Neumega) (1 trial)
oxaliplatin (eloxatin) (10 trials)
paritaprevir (viekira pak) (1 trial)
pegaspargase (oncaspar) (3 trials)
Raltitrexed (Tomudex) (2 trials)
rituximab (rituxan) (3 trials)
sargramostim (leukine) (5 trials)
sevelamer (renagel) (2 trials)
sirolimus (rapamune) (1 trial)
sofosbuvir (sovaldi) (2 trials)
tacrolimus (prograf) (3 trials)
thalidomide (Thalomid) (2 trials)
toripalimab (LOQTORZ) (7 trials)
tranexamic acid (cyklokapron) (1 trial)
umbilical cord mesenchymal stem cells (2 trials)
ursodeoxycholic acid (1 trial)
venetoclax (venclexta) (3 trials)
allogeneic adipose derived mesenchymal stem cell (2 trials)
allogeneic hematopoietic stem cells (Hemacord) (2 trials)
allogeneic natural killer cells (1 trial)
allogeneic stem cells (1 trial)
autologous cd34+ cells (1 trial)
autologous endothelial progenitor cells (1 trial)
azithromycin (zithromax) (3 trials)
bacille calmette-guerin (1 trial)
belimumab (benlysta) (1 trial)
cd44v6-specific car gene-engineered t cells (1 trial)
disodium adenosine triphosphate (1 trial)
duvelisib (copiktra) (1 trial)
Efbemalenograstim alpha (Ryzneuta) (1 trial)
fluoxetine (prozac) (2 trials)
fruquintinib (Fruzaqla) (1 trial)
gemcitabine (gemzar) (3 trials)
granisetron (kytril) (1 trial)
itraconazole (sporanox) (1 trial)
lactobacillus plantarum (1 trial)
lenalidomide (revlimid) (2 trials)
lenvatinib (lenvima) (2 trials)
masct:multiple antigens specific cellular therapy (1 trial)
methylprednisolone (medrol) (1 trial)
muc1/cll1/cd33/cd38/cd56/cd123-specific gene-engineered t cells (1 trial)
multiple signals loaded dendritic cells vaccine (1 trial)
obinutuzumab (gazyva) (1 trial)
akkermansia muciniphila (1 trial)
albuterol (proventil) (1 trial)
allogeneic cord blood (1 trial)
apalutamide (erleada) (2 trials)
autologous hair follicle derived mesenchymal stem cell (1 trial)
autologous hematopoietic stem cells (1 trial)
autologous microbiome (1 trial)
autologous platelets (1 trial)
benazepril (lotensin) (3 trials)
bifidobacterium lactis (1 trial)
ciltacabtagene autoleucel (Carvykti) (1 trial)
dexmedetomidine (precedex) (1 trial)
furazolidone (furoxone) (1 trial)
haplo-identical hematopoietic stem cells (1 trial)
hemopoietic stem cell (3 trials)
hydrocortisone (solu-cortef) (1 trial)
isomalto-oligosaccharide (1 trial)
Lactobacillus acidophilus (1 trial)
lactobacillus gasseri (1 trial)
lactobacillus reuteri (1 trial)
levofloxacin (levaquin) (1 trial)
metronidazole (flagyl) (1 trial)
mupirocin (bactroban) (1 trial)
norepinephrine (levophed) (1 trial)
omega-3 fatty acids (Omacor) (1 trial)
oxytocin (syntocinon) (1 trial)
Acute Disease (Phase 3)
Agnosia (Phase 4)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Ankylosis (Phase 3)
Asthma (Phase 4)
Atrial Fibrillation (Phase 4)
beta-Thalassemia (Phase 2)
Bone Diseases (Phase 3)
Bronchiolitis (Phase 2)
Bronchiolitis Obliterans (Phase 2)
Bronchopulmonary Dysplasia (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Adenosquamous (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma in Situ (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Cerebral Infarction (Phase 2)
Cerebral Small Vessel Diseases (Phase 4)
Cholestasis (Phase 3)
Chronic Disease (Phase 4)
Cognitive Dysfunction (Phase 4)
Coinfection (Phase 3)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Communicable Diseases (Phase 3)
Congenital Abnormalities (Phase 3)
Crohn Disease (Phase 3)
Cytomegalovirus Infections (Phase 2)
Death (Phase 1)
Delayed Emergence from Anesthesia (Phase 4)
Dementia (Phase 2)
Dementia, Vascular (Phase 2)
Depression (Phase 2)
Depressive Disorder (Phase 2)
Depressive Disorder, Major (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Foot (Phase 1)
Diabetic Nephropathies (Phase 4)
Dry Eye Syndromes (Phase 3)
Esophageal Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 3)
Fatty Liver (Phase 4)
Fibrosis (Phase 4)
Glaucoma (Phase 3)
Graft vs Host Disease (Phase 4)
Hematologic Diseases (Phase 3)
Hemorrhage (Phase 4)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 3)
Hepatitis, Chronic (Phase 4)
Hyperbilirubinemia (Phase 4)
Hyperbilirubinemia, Neonatal (Phase 4)
Hyperhomocysteinemia (Phase 4)
Hyperphosphatemia (Phase 3)
Hypertension (Phase 4)
Hypertension, Portal (Phase 4)
Infarction (Phase 2)
Infarction, Middle Cerebral Artery (Phase 2)
Infections (Phase 3)
Infertility (Phase 4)
Influenza, Human (Phase 4)
Ischemia (Phase 1)
Keratoconjunctivitis Sicca (Phase 3)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Leukemia (Phase 4)
Leukemia, B-Cell (Phase 3)
Leukemia, Erythroblastic, Acute (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 4)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, T-Cell (Phase 3)
Liver Cirrhosis (Phase 4)
Liver Diseases (Phase 4)
Liver Neoplasms (Phase 1)
Lung Diseases (Phase 4)
Lung Diseases, Interstitial (Phase 2)
Lung Diseases, Obstructive (Phase 4)
Lung Neoplasms (Phase 3)
Lupus Nephritis (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Peripheral (Phase 3)
Multiple Myeloma (Phase 3)
Musculoskeletal Diseases (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myocardial Stunning (Phase 4)
Nasopharyngeal Carcinoma (Phase 3)
Neoplasm Metastasis (Phase 2)
Neoplasm, Residual (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Nephritis (Phase 3)
Nephrosis (Phase 3)
Nephrotic Syndrome (Phase 3)
Neuroblastoma (Phase 2)
Neuromyelitis Optica (Phase 4)
Neurotoxicity Syndromes (Phase 3)
Neutropenia (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 4)
Osteosarcoma (Phase 4)
Ovarian Neoplasms (Phase 3)
Peripheral Arterial Disease (Phase 1)
Peripheral Vascular Diseases (Phase 1)
Peritoneal Neoplasms (Phase 3)
Philadelphia Chromosome (Phase 3)
Polycystic Ovary Syndrome (Phase 3)
Postoperative Complications (Phase 4)
Preleukemia (Phase 1)
Premature Birth (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Recurrence (Phase 4)
Renal Insufficiency (Phase 2)
Renal Insufficiency, Chronic (Phase 4)
Retinitis (Phase 1)
Retinitis Pigmentosa (Phase 1)
Sepsis (Phase 2)
Shock, Septic (Phase 2)
Soft Tissue Neoplasms (Phase 1)
Spinal Diseases (Phase 3)
Spondylarthritis (Phase 4)
Spondylarthropathies (Phase 3)
Spondylitis (Phase 4)
Spondylitis, Ankylosing (Phase 4)
Stomach Neoplasms (Phase 3)
Stroke (Phase 4)
Syndrome (Phase 3)
Thalassemia (Phase 2)
Thrombocytopenia (Phase 3)
Thrombosis (Phase 3)
Toxemia (Phase 2)
Urinary Bladder Neoplasms (Phase 1)
Uterine Cervical Neoplasms (Phase 2)
Vascular Diseases (Phase 1)
Vascular Malformations (Phase 3)
Virus Diseases (Phase 2)